Tumor necrosis factor-a antisense transfer remarkably improves hepatic graft viability

Liver International : Official Journal of the International Association for the Study of the Liver
Tomoharu YoshizumiKatsuo Sueishi

Abstract

Cold ischemia/reperfusion injury of the hepatic graft, an unsolved problem in liver transplantations, is attributed to the release of inflammatory cytokines, especially the tumor necrosis factor- (TNF) alpha, from activated Kupffer cells (KC). Therefore, the specific inhibition of TNF-alpha could improve the viability of the hepatic graft upon reperfusion. We assessed the efficacy of TNF-alpha antisense (TNF-AS) oligodeoxynucleotides (ODNs) delivery to KC in a rodent liver transplantation model. Seventy-one percent of the animals that received 6 hours preserved grafts in baths of lactated Ringer's solution (4 degrees C) and were treated with TNF-AS survived for over 14 days. Eighty percent of the animals treated with vehicle, sense ODNs, or balanced salt saline (BSS) died. Four hours after reperfusion of the liver, a significant reduction was noted in livers treated with TNF-AS in the release of cytosolic enzymes from the hepatocytes and the serum TNF-alpha (P<0.05). The expressions of TNF-alpha on KC and of intercellular adhesion molecule-1 on sinusoidal endothelial cells were completely suppressed in TNF-AS-treated livers. TNF-AS delivery improves the viability of the hepatic graft, and this technique may solve hepatic graft ...Continue Reading

References

May 11, 1992·Transplantation·W A KillingerG Johnson
Aug 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M GotoT Kamada
Aug 1, 1985·Experimental Cell Research·M NakanishiY Okada
Oct 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H N SankaryJ Williams
Jul 1, 1995·Gastroenterology·H ImamuraP M Huet
Mar 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L M CollettiR M Strieter
Feb 20, 1997·Nature·J W Nyce, W J Metzger
May 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C A BradhamD A Brenner
Feb 4, 1999·Nature Medicine·T UekiJ Fujimoto

❮ Previous
Next ❯

Citations

Mar 4, 2008·World Journal of Surgery·Soichiro MurataNobuhiro Ohkohchi
Jun 17, 2011·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Brandon C PerryLuis H Toledo-Pereyra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.